Fred Hutch Lands $4M for HTS-Driven Stratified Cancer Studies | GenomeWeb

NEW YORK (GenomeWeb News) – Investigators at the Fred Hutchinson Cancer Research Center will use a $4 million award from the National Cancer Institute to identify new classes of drug targets and develop criteria for stratifying patients based on who will benefit from those new therapeutics, the center said on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.